Avant Immunotherapeutics CEO to Present at the Needham & Company Biotechnology & Medical Technology Conference

Published: Jun 04, 2008

NEEDHAM, Mass.--(BUSINESS WIRE)--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Anthony S. Marucci, Interim President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the Seventh Annual Needham & Company, LLC Biotechnology & Medical Technology Conference at the New York Palace Hotel in New York City on Wednesday, June 11 at 11:30 am, EDT.

Back to news